1. Home
  2. GHG vs ELDN Comparison

GHG vs ELDN Comparison

Compare GHG & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.71

Market Cap

205.1M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.65

Market Cap

120.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
ELDN
Founded
2004
2004
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.1M
120.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GHG
ELDN
Price
$1.71
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
15.7K
1.9M
Earning Date
12-23-2025
11-14-2025
Dividend Yield
5.78%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$174,012,060.00
N/A
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$6.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$1.35
52 Week High
$3.25
$4.98

Technical Indicators

Market Signals
Indicator
GHG
ELDN
Relative Strength Index (RSI) 29.21 39.08
Support Level $1.66 $1.47
Resistance Level $1.89 $1.76
Average True Range (ATR) 0.08 0.12
MACD -0.01 0.07
Stochastic Oscillator 24.00 68.92

Price Performance

Historical Comparison
GHG
ELDN

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: